SHARMA PANNA 4
4 · Lantern Pharma Inc. · Filed Aug 9, 2022
Insider Transaction Report
Form 4
SHARMA PANNA
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-08-06+100,000→ 100,000 totalExercise: $5.60Exp: 2032-08-06→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options will vest and first become exercisable in equal monthly increments over a 36-month period commencing September 8, 2022, with the vesting of the options to accelerate in the event the closing price for our common stock is at least $15.00 per share.